GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thyrocare Technologies Ltd (NSE:THYROCARE) » Definitions » Revenue

Thyrocare Technologies (NSE:THYROCARE) Revenue : ₹5,719 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Thyrocare Technologies Revenue?

Thyrocare Technologies's revenue for the three months ended in Mar. 2024 was ₹1,543 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹5,719 Mil. Thyrocare Technologies's Revenue per Share for the three months ended in Mar. 2024 was ₹30.83. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹108.44.

During the past 12 months, the average Revenue per Share Growth Rate of Thyrocare Technologies was 9.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 5.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 10 years, Thyrocare Technologies's highest 3-Year average Revenue per Share Growth Rate was 21.40% per year. The lowest was 5.10% per year. And the median was 13.10% per year.


Thyrocare Technologies Revenue Historical Data

The historical data trend for Thyrocare Technologies's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thyrocare Technologies Revenue Chart

Thyrocare Technologies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,342.60 4,946.20 5,888.60 5,266.70 5,718.80

Thyrocare Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,358.80 1,348.90 1,480.00 1,347.40 1,542.50

Competitive Comparison of Thyrocare Technologies's Revenue

For the Diagnostics & Research subindustry, Thyrocare Technologies's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thyrocare Technologies's Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thyrocare Technologies's Revenue distribution charts can be found below:

* The bar in red indicates where Thyrocare Technologies's Revenue falls into.



Thyrocare Technologies Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5,719 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Thyrocare Technologies  (NSE:THYROCARE) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Thyrocare Technologies Revenue Related Terms

Thank you for viewing the detailed overview of Thyrocare Technologies's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Thyrocare Technologies (NSE:THYROCARE) Business Description

Traded in Other Exchanges
Address
D-37/1, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Other. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company primarily earns majority of its revenue from Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.

Thyrocare Technologies (NSE:THYROCARE) Headlines

No Headlines